Synthekine Inc.

About Synthekine Inc.

Synthekine is focused on discovering, developing, and commercializing the next generation of selective cytokine therapeutics to transform the treatment paradigms for cancer, autoimmune, inflammatory, and metabolic diseases.

Products & Services

Cytokine Therapeutics:Engineered selective cytokine therapeutics including partial agonists and surrogate agonists to address limitations of current treatments.

STK-012:A specific program within their pipeline targeting therapeutic applications.

Legacy Programs:Older programs in their development pipeline for various treatments.

Cytokine Engineering Platforms:Proprietary technologies for developing selective immunotherapies.

SYNERGY-101 Phase 2 Study:Clinical trial focused on Non-Small Cell Lung Cancer.

Specialties

Cytokine Therapeutics Immunotherapy Cancer Treatment Autoimmune Diseases Inflammatory Diseases Metabolic Diseases Cytokine Engineering

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 100000000 MR: - FA: 100 million FAN: 100000000	D: 2023-01-06 FD: 2023-01-06	1 investors

Series C Latest

2023-01-06

$100.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

K. Christopher Garcia

Professor of Molecular and Cellular Physiology and Structural Biology

D

Debanjan Ray

President and Chief Executive Officer

M

Martin Oft

Chief Scientific Officer

N

Naiyer Rizvi

Chief Medical Officer

G

Gregory Yedinak

Chief Technical Officer

G

Geoff Nosrati

Chief Business Officer

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

Synthekine Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised